Longview Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,136,426
| Closed | -$276M | – | 27 |
|
|
2023
Q1 | $276M | Buy |
2,136,426
+74,935
| +4% | +$9.41M | 1.95% | 25 |
|
|
2022
Q4 | $263M | Sell |
2,061,491
-23,040
| -1% | -$2.67M | 2.09% | 25 |
|
|
2022
Q3 | $218M | Sell |
2,084,531
-131,076
| -6% | -$14.4M | 1.87% | 27 |
|
|
2022
Q2 | $233M | Sell |
2,215,607
-840
| -0% | -$99.7K | 1.78% | 25 |
|
|
2022
Q1 | $283M | Sell |
2,216,447
-128,899
| -5% | -$15.5M | 1.86% | 23 |
|
|
2021
Q4 | $289M | Sell |
2,345,346
-153,792
| -6% | -$20.1M | 1.85% | 22 |
|
|
2021
Q3 | $355M | Buy |
2,499,138
+1,314,338
| +111% | +$193M | 2.24% | 21 |
|
|
2021
Q2 | $185M | Sell |
1,184,800
-111,925
| -9% | -$18.1M | 1.02% | 24 |
|
|
2021
Q1 | $202M | Sell |
1,296,725
-225,571
| -15% | -$34.9M | 1.07% | 25 |
|
|
2020
Q4 | $228M | Sell |
1,522,296
-349,278
| -19% | -$49.3M | 1.11% | 24 |
|
|
2020
Q3 | $247M | Sell |
1,871,574
-3,955
| -0.2% | -$517K | 1.16% | 23 |
|
|
2020
Q2 | $217M | Buy |
+1,875,529
| New | +$216M | 1.03% | 25 |
|
|
2019
Q2 | – | Sell |
-2,368,992
| Closed | -$294M | – | 25 |
|
|
2019
Q1 | $294M | Sell |
2,368,992
-4,275,564
| -64% | -$486M | 1.55% | 21 |
|
|
2018
Q4 | $669M | Sell |
6,644,556
-121,693
| -2% | -$13.7M | 3.56% | 18 |
|
|
2018
Q3 | $864M | Sell |
6,766,249
-1,215,112
| -15% | -$144M | 4.26% | 15 |
|
|
2018
Q2 | $864M | Sell |
7,981,361
-96,017
| -1% | -$10.5M | 4.5% | 15 |
|
|
2018
Q1 | $855M | Sell |
8,077,378
-191,264
| -2% | -$22.2M | 4.48% | 15 |
|
|
2017
Q4 | $969M | Buy |
8,268,642
+536,757
| +7% | +$60.7M | 5.07% | 9 |
|
|
2017
Q3 | $879M | Buy |
7,731,885
+1,162,843
| +18% | +$134M | 4.75% | 11 |
|
|
2017
Q2 | $819M | Buy |
6,569,042
+277,259
| +4% | +$32.9M | 4.72% | 7 |
|
|
2017
Q1 | $746M | Sell |
6,291,783
-344,634
| -5% | -$39.1M | 4.85% | 5 |
|
|
2016
Q4 | $665M | Buy |
6,636,417
+155,654
| +2% | +$16.7M | 4.39% | 13 |
|
|
2016
Q3 | $818M | Sell |
6,480,763
-73,388
| -1% | -$9.07M | 5.3% | 1 |
|
|
2016
Q2 | $766M | Sell |
6,554,151
-231,544
| -3% | -$26.2M | 5.1% | 2 |
|
|
2016
Q1 | $702M | Sell |
6,785,695
-133,344
| -2% | -$12.9M | 4.67% | 11 |
|
|
2015
Q4 | $689M | Buy |
6,919,039
+3,635,195
| +111% | +$356M | 4.7% | 5 |
|
|
2015
Q3 | $299M | Buy |
+3,283,844
| New | +$329M | 2.12% | 24 |
|
|
2013
Q4 | – | Sell |
-2,016,213
| Closed | -$161M | – | 23 |
|
|
2013
Q3 | $161M | Sell |
2,016,213
-3,515,827
| -64% | -$277M | 1.49% | 21 |
|
|
2013
Q2 | $402M | Buy |
+5,532,040
| New | +$414M | 4% | 18 |
|
Other funds holding ZBH
Longview Partners's ZBH Position: Q2 2023 in Review
Longview Partners sold out of Zimmer Biomet (ZBH) in Q2 2023, closing a stake of 2,136,426 shares — an estimated $276M sold.
Longview Partners first reported a position in ZBH in Q2 2013 and held it in 29 quarters. The position peaked at $969M in Q4 2017. 1,032 funds tracked by Wall St. Rank hold ZBH as of Q2 2023.
- Longview Partners reported no remaining Zimmer Biomet position as of Q2 2023 after selling out during the quarter.
- Longview Partners sold 2,136,426 Zimmer Biomet shares in Q2 2023, an estimated $276M.
- Longview Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 29 quarters.
- Longview Partners's Zimmer Biomet position peaked at $969M in Q4 2017.
- 1,032 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2023.
Based on Longview Partners's 13F filing for Q2 2023, filed 11 Aug 2023.